The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
D000293:Adolescent; D000328:Adult; D001480:Basal Ganglia Diseases / Q000378:metabolism; D002547:Cerebral Palsy / Q000188:drug therapy; D002552:Cerebral Ventricles / Q000378:metabolism; D003975:Diazepam / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004314:Down Syndrome / Q000188:drug therapy / Q000378:metabolism; D004422:Dystonia Musculorum Deformans / Q000378:metabolism; D004827:Epilepsy / Q000378:metabolism*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D007223:Infant; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000378:metabolism*; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D010591:Phantom Limb / Q000188:drug therapy / Q000378:metabolism; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011732:Pyridoxal Phosphate / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism*; D013129:Spinal Puncture; D014103:Torticollis / Q000188:drug therapy / Q000378:metabolism
D010648:Phenylacetates; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D011732:Pyridoxal Phosphate; D004295:Dihydroxyphenylalanine; D003975:Diazepam